Certara Appoints new Chief Marketing Officer, Sheila Rocchio Announcement Certara Appoints new Chief Marketing Officer, Sheila Rocchio Princeton, N.J., 2023 年 6 月 13 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in biosimulation, today…Certara2023 年 6 月 14 日
What’s New for SEND 2023 On-Demand Webinar SEND 2023 的新变化 This webinar will focus on several changes to the CDISC SEND standard that became active…Certara2023 年 6 月 12 日
Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development Announcement Certara 推出用于药物开发的 Phoenix™ 生物模拟软件 8.4 版 Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…Certara2023 年 6 月 12 日
Certara enhances CODEX Clinical Outcome Analytics Platform with AI Announcement Certara enhances CODEX Clinical Outcome Analytics Platform with AI Trial design and execution now accelerated by deep learning and data fabric capabilities. PRINCETON, NJ…Certara2023 年 6 月 8 日
Unlocking Efficiency and Quality: What is New in Phoenix™ 8.4? 网络研讨会点播 提高效率和质量:What is New in Phoenix™ 8.4? Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…Certara2023 年 6 月 5 日
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Publication QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…Certara2023 年 5 月 25 日
Dose Optimization: Getting it Right for Vulnerable Populations Press Coverage Dose Optimization: Getting it Right for Vulnerable Populations By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…Certara2023 年 5 月 22 日
Japan’s Approach to Pediatric Drug Development: What You Need to Know Blog 日本儿科药物开发方法:您需要了解的信息 Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…Certara2023 年 5 月 22 日
Certara’s Synchrogenix Writer now enhanced with AI Layar Announcement Certara’s Synchrogenix Writer now enhanced with AI Layar Next generation automation for Medical Writers to streamline the creation of regulatory documents Certara is…Certara2023 年 5 月 11 日
The Impact of the Inflation Reduction Act on Biosimilar Uptake Press Coverage The Impact of the Inflation Reduction Act on Biosimilar Uptake In an interview with HCPLive, Maximilian Vargas, PhD, MBA, vice president of the United States…Certara2023 年 5 月 8 日